arXiv · 2401.02149
AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptors
Abstract
Comparison of click chemistry and sortagging grafting strategies for functionalizing AGuIX nanoparticles with nanobodies to develop a tri-functional technology combining MRI imaging, radiotherapy, and immunotherapy by inhibiting immune checkpoints.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Léna Carmès, Guillaume Bort, François Lux, Léa Seban, Paul Rocchi, Zeinaf Muradova, Agnès Hagège, Laurence Heinrich-Balard, Frédéric Delolme, Virginie Gueguen-Chaignon, Charles Truillet, Stephanie Crowley, Elisa Bello, Tristan Doussineau, Michael Dougan, Olivier Tillement, Jonathan Schoenfeld, Needa Brown, Ross Berbeco. 2024-01-04. AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptors. https://doi.org/10.1039/d3nr04777f
Cite the original work for its findings. Save a collection to share your selection of sources.